[CAS NO. 56-47-3]  Deoxycorticosterone acetate

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [56-47-3]

Catalog
HY-B1472
Brand
MCE
CAS
56-47-3

DESCRIPTION [56-47-3]

Overview

MDLMFCD00003660
Molecular Weight372.50
Molecular FormulaC23H32O4
SMILESC[C@@]12[C@@H](C(COC(C)=O)=O)CC[C@@]1([H])[C@]3([H])CCC4=CC(CC[C@]4(C)[C@@]3([H])CC2)=O

For research use only. We do not sell to patients.

Summary

Deoxycorticosterone acetate (DOCA) is an adrenocortin, acts as a precursor to aldosterone. Deoxycorticosterone acetate is a mineralocorticoid receptor agonist. Deoxycorticosterone acetate can cause severe renal injury, including inflammation, fibrosis, glomerular damage, and proteinuria [1] [2] .


IC50 & Target

Human Endogenous Metabolite


In Vivo

Deoxycorticosterone acetate (2.5 mg/d; s.c. implantation; 42 d; 2 mg/d Tamoxifen (HY-13757A) pre-treatment) induces hypertension by increasing blood pressure and cardiac hypertrophy in mice [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: MR (mineralocorticoid receptor) mutant mice (MR Cdh5Cre ) and MR wild-type mice (MR wild-type ) treated with unilateral nephrectomy (12-week-old) [1]
Dosage: 2.5 mg/d
Administration: Subcutaneous implantation; 42 days; treated with 2 mg Tamoxifen (HY-13757A) (20 mg/mL in sunflower oil and 10% ethanol; i.p.; once daily on 5 consecutive days) at least 4 weeks before nephrectomy
Result: Increased the blood pressure without differences between both genotypes (MR Cdh5Cre and MR wild-type ).
Resulted glomerular injury and proteinuria, renal inflammation and fibrosis.

Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month

Solvent & Solubility

In Vitro:

DMSO : 41.67 mg/mL ( 111.87 mM ; ultrasonic and warming and heat to 80°C)

H 2 O : 1 mg/mL ( 2.68 mM ; ultrasonic and warming and heat to 80°C)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.6846 mL 13.4228 mL 26.8456 mL
5 mM 0.5369 mL 2.6846 mL 5.3691 mL
10 mM 0.2685 mL 1.3423 mL 2.6846 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.08 mg/mL (5.58 mM); Clear solution

  • 2.

    Add each solvent one by one: 10% DMSO >> 90% corn oil

    Solubility: ≥ 2.08 mg/mL (5.58 mM); Clear solution

  • 3.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

    Solubility: ≥ 1.67 mg/mL (4.48 mM); Clear solution

* All of the co-solvents are available by MCE.


Synonyms

Pregn-4-ene-3,20-dione, 21-(acetyloxy)-
11-Deoxycorticosterone, acetate
Pregn-4-ene-3,20-dione, 21-hydroxy-, acetate
21-(Acetyloxy)pregn-4-ene-3,20-dione
21-Acetoxy-3,20-diketopregn-4-ene
Cortacet
Cortate
Cortenil
Cortesan
Cortexone acetate
Cortifar
Cortigen
Cortinaq
Cortiron
Cortivis
Cortixyl
DCA
Decortin
Decorten
Decosterone
Decostrate
11-Deoxycorticosterone 21-acetate
Deoxycorticosterone acetate
Deoxycorticosterone 21-acetate
Deoxycortone acetate
Descorterone
Descotone
Desoxycorticosterone acetate
Desoxycortone acetate
DOC acetate
Dorcostrin
Doxo
21-Hydroxypregn-4-ene-3,20-dione 21-acetate
21-Hydroxypregn-4-ene-3,20-dione acetate
Krinocorts
11-Desoxycorticosterone acetate
Ocriten
Percorten
Percotol
4-Pregnene-3,20-dione 21-acetate
4-Pregnene-3,20-dione-21-ol acetate
Primocort
Primocortan
Sincortex
Steraq
Syncort
Syncorta
Syncortyl
Unidocan
DOCA
21-Acetoxypregn-4-ene-3,20-dione
21-Acetoxypregn-4-en-3,20-dione
Doxycamon
Arcort
Ocritena
Bio-Corten
Decosteron
NSC 9567
21-Hydroxyprogesterone 21-acetate